An R&D Blueprint for Action to Prevent Epidemics

Plan of Action, World Health Organization, May 2016

48 pp. 12.5 MB

At the request of its 194 Member States, WHO has convened a broad global coalition to develop the Research & Development (R&D) Blueprint as a platform for accelerating R&D. The R&D Blueprint is intended to focus on severe emerging diseases with potential to generate a public health emergency, and for which no, or insufficient, preventative and curative solutions exist. The methodology under review identifies those diseases which most readily meet these characteristics.

The updated 2017 list of priority diseases include:

(Visited 30 times, 1 visits today)
This entry was posted in Essential Medicines, General, Other Infectious Diseases. Bookmark the permalink.